Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 31

Trial Status

Other1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT01844986Phase 3Active Not Recruiting
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
Advanced Ovarian CancerBRCA MutationComplete Response+4 more
PrincipalinvestigatorStart date: 2013-08-26

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Prof Paul DiSilvestro, MD

Women & Infants Hospital, Providence, Rhode Island, USA

Very Similar
1 trials

Shared therapeutic areas:

Advanced Ovarian CancerBRCA Mutated Advanced (FIGO Stage III-IV) Ovarian CancerBRCA Mutation+5 more

Worked with same sponsors:

AstraZenecaGOG Foundation+2 more
Collaborated on 1 trial
Similarity Score84%

Jianping Weng, Doctor

Third Affiliated Hospital, Sun Yat-Sen University

Related
2 trials

Shared therapeutic areas:

Newly Diagnosed
Similarity Score4%

Giorgio Senaldi, MD, PhD

Daiichi Sankyo

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer
Similarity Score4%

Sahar Salehi, MD, PhD

Karolinska Institute and Karolinska University Hospital

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer
Similarity Score4%

Philipp Harter

European Network of Gynaecological Oncological Trial Groups (ENGOT)

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer

Worked with same sponsors:

AstraZenecaGOG Foundation+1 more
Similarity Score4%

Jane Robertson, BSc, MBCHB, MD

AstraZeneca

Related
12 trials

Shared therapeutic areas:

Advanced Ovarian Cancer

Worked with same sponsors:

AstraZeneca
Similarity Score4%

Cyril Salek, MD

Institute of Hematology and Blood Transfusion, Czech Republic

Related
2 trials

Shared therapeutic areas:

Newly Diagnosed
Similarity Score4%

H.W.M. van Laarhoven, Md PhD

Radboud University Medical Center

Related
1 trials

Shared therapeutic areas:

BRCA Mutation
Similarity Score4%

TONG Zhongsheng

Professor of Medicine

Related
1 trials

Shared therapeutic areas:

BRCA Mutation
Similarity Score4%

hisham abo taleb, lecturer

Assiut University

Related
1 trials

Shared therapeutic areas:

Advanced Ovarian Cancer
Similarity Score4%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT01844986Phase 3PrincipalInvestigator

Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.

Advanced Ovarian CancerBRCA MutationComplete Response+4 more
Active Not Recruiting

All 1 trials loaded